Form 8-K

Send us Feedback

Bristol-Myers Squibb Company (BMY)

	SUMMARY

	BULLS

	BEARS

	TOPICS

	DATA CENTRAL

	STOCK CHART

	SEC FILINGS

	BALANCE

	INCOME

	CASH FLOW

Annual Reports

Quarterly Reports

8-K

8-K (Oct 24, 2012)8-K (Oct 3, 2012)8-K (Aug 24, 2012)8-K (Aug 10, 2012)8-K (Aug 3, 2012)8-K (Jul 31, 2012)8-K (Jul 25, 2012)8-K (Jul 3, 2012)8-K (May 7, 2012)8-K (Apr 26, 2012)8-K (Mar 8, 2012)8-K (Jan 26, 2012)8-K (Jan 24, 2012)8-K (Jan 9, 2012)8-K (Oct 27, 2011)8-K (Oct 21, 2011)8-K (Oct 4, 2011)8-K (Jul 28, 2011)8-K (Jul 12, 2011)8-K (May 6, 2011)8-K (Apr 28, 2011)8-K (Mar 4, 2011)8-K (Jan 27, 2011)8-K (Nov 9, 2010)8-K (Oct 26, 2010)8-K (Oct 12, 2010)8-K (Sep 10, 2010)8-K (Jul 22, 2010)8-K (May 10, 2010)8-K (Apr 29, 2010)8-K (Mar 8, 2010)8-K (Mar 4, 2010)8-K (Jan 28, 2010)8-K (Dec 24, 2009)8-K (Dec 23, 2009)8-K (Dec 18, 2009)8-K (Dec 9, 2009)8-K (Dec 1, 2009)8-K (Nov 12, 2009)8-K (Oct 22, 2009)8-K (Sep 2, 2009)8-K (Aug 17, 2009)8-K (Jul 23, 2009)8-K (Apr 28, 2009)8-K (Apr 6, 2009)8-K (Mar 6, 2009)8-K (Jan 27, 2009)8-K (Oct 23, 2008)8-K (Oct 8, 2008)8-K (Sep 23, 2008)8-K (Sep 12, 2008)8-K (Sep 11, 2008)8-K (Aug 7, 2008)8-K (Aug 1, 2008)8-K (Jul 31, 2008)8-K (Jul 24, 2008)8-K (May 7, 2008)8-K (Apr 24, 2008)8-K (Mar 10, 2008)8-K (Feb 19, 2008)8-K (Feb 15, 2008)8-K (Jan 31, 2008)8-K (Jan 23, 2008)8-K (Dec 5, 2007)8-K (Nov 30, 2007)8-K (Oct 25, 2007)8-K (Sep 28, 2007)8-K (Sep 24, 2007)8-K (Aug 31, 2007)8-K (Aug 27, 2007)8-K (Jul 26, 2007)8-K (Jun 25, 2007)8-K (Jun 18, 2007)8-K (May 31, 2007)8-K (Apr 27, 2007)8-K (Apr 26, 2007)8-K (Apr 6, 2007)8-K (Apr 3, 2007)8-K (Mar 9, 2007)8-K (Feb 14, 2007)8-K (Jan 25, 2007)8-K (Dec 27, 2006)8-K (Dec 11, 2006)8-K (Nov 30, 2006)8-K (Nov 27, 2006)8-K (Nov 9, 2006)8-K (Nov 3, 2006)8-K (Oct 30, 2006)8-K (Oct 26, 2006)8-K (Sep 25, 2006)8-K (Sep 15, 2006)8-K (Sep 5, 2006)8-K (Aug 31, 2006)8-K (Aug 29, 2006)8-K (Aug 18, 2006)8-K (Jul 27, 2006)8-K (Jul 11, 2006)8-K (Jun 2, 2006)8-K (May 31, 2006)8-K (May 11, 2006)8-K (Apr 27, 2006)8-K (Apr 17, 2006)8-K (Mar 21, 2006)8-K (Mar 17, 2006)8-K (Mar 13, 2006)8-K (Feb 10, 2006)8-K (Jan 25, 2006)8-K (Jan 13, 2006)8-K (Dec 28, 2005)8-K (Dec 14, 2005)8-K (Dec 2, 2005)8-K (Dec 1, 2005)8-K (Nov 4, 2005)8-K (Oct 28, 2005)8-K (Oct 20, 2005)8-K (Oct 13, 2005)8-K (Sep 22, 2005)8-K (Sep 13, 2005)8-K (Sep 1, 2005)8-K (Aug 31, 2005)8-K (Aug 11, 2005)8-K (Jul 28, 2005)8-K (Jul 15, 2005)8-K (Jul 1, 2005)8-K (Jun 16, 2005)8-K (Jun 2, 2005)8-K (May 12, 2005)8-K (May 10, 2005)8-K (Apr 28, 2005)8-K (Mar 4, 2005)8-K (Feb 17, 2005)8-K (Jan 27, 2005)8-K (Jan 18, 2005)8-K (Jan 6, 2005)8-K (Jan 4, 2005)8-K (Dec 23, 2004)8-K (Dec 16, 2004)8-K (Dec 9, 2004)8-K (Nov 8, 2004)8-K (Oct 29, 2004)8-K (Sep 17, 2004)8-K (Sep 3, 2004)8-K (Aug 5, 2004)8-K (Jul 30, 2004)8-K (Jul 29, 2004)8-K (Jun 28, 2004)8-K (May 26, 2004)8-K (May 10, 2004)8-K (Apr 28, 2004)8-K (Apr 2, 2004)8-K (Mar 31, 2004)8-K (Mar 15, 2004)8-K (Jan 29, 2004)8-K (Oct 23, 2003)8-K (Sep 26, 2003)8-K (Jul 24, 2003)8-K (Jul 23, 2003)8-K (Apr 29, 2003)8-K (Mar 11, 2003)8-K (Mar 4, 2003)8-K (Feb 3, 2003)8-K (Nov 15, 2002)8-K (Nov 1, 2002)8-K (Nov 30, 2001)8-K (Oct 12, 2001)8-K (Sep 25, 2001)8-K (Sep 20, 2001)8-K (Sep 19, 2001)8-K (Jun 8, 2001)8-K (Jan 25, 2001)8-K (Apr 19, 2000)8-K (Jun 19, 1995)8-K (May 3, 1995)

Other

Bristol-Myers Squibb Company 8-K 2009

Documents found in this filing:

Form 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): December 23, 2009

BRISTOL-MYERS SQUIBB COMPANY

(Exact Name of Registrant as Specified in its Charter)

Delaware

1-1136

22-079-0350

(State or Other Jurisdiction

of Incorporation)

(Commission

File Number)

(IRS Employer

Identification Number)

345 Park Avenue

New York, NY, 10154

(Address of Principal Executive Office)

Registrant’s telephone number, including area code: (212) 546-4000

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 2.02.

Completion of Acquisition or Disposition of Assets

On December 23, 2009, Bristol-Myers Squibb Company (the “Company”) completed the previously announced split-off of its 83.1 percent ownership in Mead Johnson Nutrition Company (“Mead Johnson”) to tendering shareholders of the Company. The split-off was effected through the exchange of the Company’s previously held 170 million shares of Mead Johnson Nutrition Company for 269,285,601 outstanding shares of the Company’s stock. The exchange offer was over subscribed.

A copy of the joint press release of the Company and Mead Johnson announcing the completion of the divestiture is attached hereto as Exhibit 99.1.

Item 8.01.

Other Events.

On December 23, 2009, the Company issued a press release announcing that it is updating its previously disclosed full year 2009 earnings per share from continuing operations guidance. A copy of the press release is furnished as Exhibit 99.2 to this report and incorporated herein by reference.

Item 9.01.

Financial Statements and Exhibits.

(b) Pro Forma Financial Information

The Company’s unaudited pro forma financial information as required under Rule 11-01 of Regulation S-X is attached hereto as Exhibit 99.2 and is incorporated herein by reference.

(d) Exhibits.


99.1		Press release of Bristol-Myers Squibb Company and Mead Johnson Nutrition Company dated December 23, 2009

99.2		Press release of Bristol-Myers Squibb Company dated December 23, 2009

99.3		The Company’s Unaudited Pro Forma Financial Information

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


	BRISTOL-MYERS SQUIBB COMPANY

Dated: December 24, 2009	By:	/S/ SANDRA LEUNG
	Name:	Sandra Leung
	Title:	Senior Vice President and General Counsel

EXHIBIT INDEX


Exhibit No.		Description

99.1		Press release of Bristol-Myers Squibb Company and Mead Johnson Nutrition Company dated December 23, 2009

99.2		Press release of Bristol-Myers Squibb Company dated December 23, 2009

99.3		The Company’s Unaudited Pro Forma Financial Information

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.

Mobile | Advertise | Licensing & Partnerships | Blogger Tools | Jobs

Bristol-Myers Squibb Company (BMY)

Annual Reports

Quarterly Reports

8-K

Other

Documents found in this filing: